Cure My Disease

Don't miss your cure!

 Log in / Sign up

Waiting to clamp the cord: could 30 seconds save preterm babies?

NCT ID NCT07699666

Disease control Sponsor: Faculty of Medicine of Tunis Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study compares delayed cord clamping (waiting at least 30 seconds after birth) with immediate clamping in preterm infants born between 32 and 37 weeks. The goal is to see if the extra time improves early health outcomes such as breathing, anemia risk, and survival. Researchers in Tunisia will track complications like necrotizing enterocolitis and brain bleeding in about 200 newborns.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Delayed umbilical cord clamping (procedure)
What this could lead to
If delayed clamping proves better, it could become standard practice for preterm births, reducing complications like anemia and breathing problems.
What could go wrong
This is a single-center study with 200 infants, so results may not apply everywhere. Delayed clamping might not show clear benefits and could delay urgent care in some cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

0 days and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Preterm neonates born at gestational age between 32 and 37 weeks * Live-born infants delivered in the study center * Singleton pregnancies * Parental consent obtained when applicable according to institutional ethical requirements Exclusion Criteria: * Major congenital malformations or chromosomal abnormalities * Need for immediate advanced resuscitation at birth * Severe fetal distress requiring emergency obstetric intervention incompatible with protocol allocation * Placental conditions contraindicating delayed cord clamping (e.g., placental abruption with maternal instability, placenta previa bleeding, Placenta accreta spectrum) * Intra Uterin Growth Restriction with abnormal umbilical artery Doppler velocimetry

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anemia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anemia Hyaline Membrane Disease necrotizing enterocolitis neonatal respiratory failure newborn respiratory distress syndrome Premature Birth twin to twin transfusion syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anemia Cord clamping Delayed cord clamping Intraventricular hemorrhage neonatal Nec - necrotizing enterocolitis Neonatal morbidity and mortality Preterm birth complication Respiratory distress neonatal

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Maternity and neonatology center of Tunis

    RECRUITING

    Tunis, Tunis Governorate, 1007, Tunisia

More trials for these conditions

Other studies related to the condition(s) this trial covers.